<p>CARGO Therapeutics（纳斯达克代码：CRGX - 获取免费报告）在周五发布的研究报告中被华尔街 Zen 的股票研究人员上调至 “卖出” 评级。</p>
<ul>
<li>2024 年 IPO 观察：哪些新股票将上市？</li>
</ul>
<p>另外，杰富瑞金融集团在 7 月 8 日的报告中将 CARGO Therapeutics 的目标价格从 3.70 美元上调至 5.00 美元，并给予该股票 “持有” 评级。六位分析师对该股票给予了 “持有” 评级，一位分析师给予了 “卖出” 评级。根据 MarketBeat 的数据，CARGO Therapeutics 的共识评级为 “减持”，平均目标价格为 15.40 美元。</p>
<p>获取 <strong>CARGO Therapeutics</strong> 的提醒：</p>
<p><strong>查看我们关于 CARGO Therapeutics 的最新股票报告</strong></p>
<h2>CARGO Therapeutics 价格表现</h2>
<p>CRGX 股票在周五开盘价为 4.47 美元。该股票的 50 日移动平均价为 4.44 美元，200 日移动平均价为 4.23 美元。CARGO Therapeutics 的 52 周最低价为 3.00 美元，52 周最高价为 25.45 美元。该公司的市值为 2.1617 亿美元，市盈率为-0.96，贝塔值为 0.30。</p>
<h2>对 CARGO Therapeutics 的对冲基金看法</h2>
<p>机构投资者和对冲基金最近调整了对该股票的持有。Ascent Group LLC 在第一季度购买了 CARGO Therapeutics 的新头寸，价值 43,000 美元。Jane Street Group LLC 在第二季度购买了 CARGO Therapeutics 的新头寸，价值 45,000 美元。XTX Topco Ltd 在第一季度购买了 CARGO Therapeutics 的新头寸，价值 46,000 美元。Brooklyn Investment Group 在第一季度将其在 CARGO Therapeutics 的持股增加了 512.3%。Brooklyn Investment Group 现在拥有 11,328 股该公司的股票，价值 46,000 美元，此前在上个季度又增持了 9,478 股。最后，洛杉矶资本管理公司在第二季度购买了 CARGO Therapeutics 的新头寸，价值 46,000 美元。目前 93.16% 的股票由机构投资者持有。</p>
<h2>关于 CARGO Therapeutics</h2>
<p>（获取免费报告）</p>
<p>CARGO Therapeutics, Inc 是一家临床阶段的生物技术公司，开发用于癌症患者的嵌合抗原受体（CAR）T 细胞疗法。该公司的主要项目是 CRG-022，一种自体 CD22 CAR T 细胞产品候选药物，旨在通过靶向 CD22 这一在 B 细胞恶性肿瘤中表达的替代肿瘤抗原来应对耐药机制。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们更看好的股票，胜过 CARGO Therapeutics</li>
<li>现在值得购买的三只巨头成长股</li>
<li>皇家加勒比的收益超出预期，推动 2025 年强劲前景</li>
<li>什么是低市盈率，它对投资者意味着什么？</li>
<li>Alphabet 的突破潜力：从落后者到 AI 领导者</li>
<li>股息贵族名单中的最佳：通过贵族指数积累财富</li>
<li>TJX 股票价格创下新高，预示着更多新高将随之而来</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1JHWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1JHWA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 CARGO Therapeutics 吗？</h2>
<p>在考虑 CARGO Therapeutics 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 CARGO Therapeutics 并不在名单上。</p>
<p>虽然 CARGO Therapeutics 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

CRGX

<p>Wall Street Zen 最近在一份研究报告中将 CARGO Therapeutics (NASDAQ:CRGX) 的评级上调至 “卖出”。Jefferies Financial Group 也将该股票的目标价从 3.70 美元上调至 5.00 美元，并维持 “持有” 评级。目前，CARGO Therapeutics 的共识评级为 “减持”，平均目标价为 15.40 美元。该股票开盘价为 4.47 美元，市值为 2.1617 亿美元。机构投资者持有该股票的 93.16%，显示出对公司的强烈兴趣</p>

<p>CARGO Therapeutics (NASDAQ:CRGX - Get Free Report) was upgraded by equities researchers at Wall Street Zen to a &#34;sell&#34; rating in a research report issued on Friday.</p>
<div class="lb-trans"><p>CARGO Therapeutics（纳斯达克代码：CRGX - 获取免费报告）在周五发布的研究报告中被华尔街 Zen 的股票研究人员上调至 “卖出” 评级。</p>
</div><ul>
<li>IPO watch 2024: Which new stocks will hit the market?</li>
</ul>
<div class="lb-trans"><ul>
<li>2024 年 IPO 观察：哪些新股票将上市？</li>
</ul>
</div><p>Separately, Jefferies Financial Group increased their price objective on CARGO Therapeutics from $3.70 to $5.00 and gave the stock a &#34;hold&#34; rating in a report on Tuesday, July 8th. Six analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, CARGO Therapeutics has a consensus rating of &#34;Reduce&#34; and an average price target of $15.40.</p>
<div class="lb-trans"><p>另外，杰富瑞金融集团在 7 月 8 日的报告中将 CARGO Therapeutics 的目标价格从 3.70 美元上调至 5.00 美元，并给予该股票 “持有” 评级。六位分析师对该股票给予了 “持有” 评级，一位分析师给予了 “卖出” 评级。根据 MarketBeat 的数据，CARGO Therapeutics 的共识评级为 “减持”，平均目标价格为 15.40 美元。</p>
</div><p>Get <strong>CARGO Therapeutics</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>CARGO Therapeutics</strong> 的提醒：</p>
</div><p><strong>Check Out Our Latest Stock Report on CARGO Therapeutics</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 CARGO Therapeutics 的最新股票报告</strong></p>
</div><h2>CARGO Therapeutics Price Performance</h2>
<div class="lb-trans"><h2>CARGO Therapeutics 价格表现</h2>
</div><p>Shares of CRGX stock opened at $4.47 on Friday. The stock has a fifty day moving average of $4.44 and a 200 day moving average of $4.23. CARGO Therapeutics has a 52 week low of $3.00 and a 52 week high of $25.45. The firm has a market capitalization of $216.17 million, a price-to-earnings ratio of -0.96 and a beta of 0.30.</p>
<div class="lb-trans"><p>CRGX 股票在周五开盘价为 4.47 美元。该股票的 50 日移动平均价为 4.44 美元，200 日移动平均价为 4.23 美元。CARGO Therapeutics 的 52 周最低价为 3.00 美元，52 周最高价为 25.45 美元。该公司的市值为 2.1617 亿美元，市盈率为-0.96，贝塔值为 0.30。</p>
</div><h2>Hedge Funds Weigh In On CARGO Therapeutics</h2>
<div class="lb-trans"><h2>对 CARGO Therapeutics 的对冲基金看法</h2>
</div><p>Institutional investors and hedge funds have recently modified their holdings of the stock. Ascent Group LLC bought a new position in shares of CARGO Therapeutics during the first quarter valued at $43,000. Jane Street Group LLC bought a new position in shares of CARGO Therapeutics during the second quarter valued at $45,000. XTX Topco Ltd bought a new position in shares of CARGO Therapeutics during the first quarter valued at $46,000. Brooklyn Investment Group increased its holdings in shares of CARGO Therapeutics by 512.3% during the first quarter. Brooklyn Investment Group now owns 11,328 shares of the company's stock valued at $46,000 after acquiring an additional 9,478 shares in the last quarter. Finally, Los Angeles Capital Management LLC bought a new position in shares of CARGO Therapeutics during the second quarter valued at $46,000. 93.16% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>机构投资者和对冲基金最近调整了对该股票的持有。Ascent Group LLC 在第一季度购买了 CARGO Therapeutics 的新头寸，价值 43,000 美元。Jane Street Group LLC 在第二季度购买了 CARGO Therapeutics 的新头寸，价值 45,000 美元。XTX Topco Ltd 在第一季度购买了 CARGO Therapeutics 的新头寸，价值 46,000 美元。Brooklyn Investment Group 在第一季度将其在 CARGO Therapeutics 的持股增加了 512.3%。Brooklyn Investment Group 现在拥有 11,328 股该公司的股票，价值 46,000 美元，此前在上个季度又增持了 9,478 股。最后，洛杉矶资本管理公司在第二季度购买了 CARGO Therapeutics 的新头寸，价值 46,000 美元。目前 93.16% 的股票由机构投资者持有。</p>
</div><h2>About CARGO Therapeutics</h2>
<div class="lb-trans"><h2>关于 CARGO Therapeutics</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>CARGO Therapeutics, Inc, a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies.</p>
<div class="lb-trans"><p>CARGO Therapeutics, Inc 是一家临床阶段的生物技术公司，开发用于癌症患者的嵌合抗原受体（CAR）T 细胞疗法。该公司的主要项目是 CRG-022，一种自体 CD22 CAR T 细胞产品候选药物，旨在通过靶向 CD22 这一在 B 细胞恶性肿瘤中表达的替代肿瘤抗原来应对耐药机制。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than CARGO Therapeutics</li>
<li>3 Monster Growth Stocks to Buy Now</li>
<li>Royal Caribbean Earnings Beat Fuels Strong 2025 Outlook</li>
<li>What is a Low P/E Ratio and What Does it Tell Investors?</li>
<li>Alphabet’s Breakout Potential: From Laggard to AI Leader</li>
<li>Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index</li>
<li>TJX Stock Price Hits Fresh High, Signals More Highs to Follow</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 CARGO Therapeutics</li>
<li>现在值得购买的三只巨头成长股</li>
<li>皇家加勒比的收益超出预期，推动 2025 年强劲前景</li>
<li>什么是低市盈率，它对投资者意味着什么？</li>
<li>Alphabet 的突破潜力：从落后者到 AI 领导者</li>
<li>股息贵族名单中的最佳：通过贵族指数积累财富</li>
<li>TJX 股票价格创下新高，预示着更多新高将随之而来</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1JHWA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=CRGX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in CARGO Therapeutics Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 CARGO Therapeutics 吗？</h2>
</div><p>Before you consider CARGO Therapeutics, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 CARGO Therapeutics 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CARGO Therapeutics wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 CARGO Therapeutics 并不在名单上。</p>
</div><p>While CARGO Therapeutics currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 CARGO Therapeutics 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

华尔街禅将 CARGO Therapeutics（NASDAQ:CRGX）的评级上调至卖出